Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.

Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K.

Br J Cancer. 2017 Mar 14;116(6):828-839. doi: 10.1038/bjc.2017.6. Epub 2017 Feb 9.

2.

Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.

Johns LE, Coleman DA, Swerdlow AJ, Moss SM.

Br J Cancer. 2017 Jan 17;116(2):246-252. doi: 10.1038/bjc.2016.415. Epub 2016 Dec 8.

3.
5.

Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Ringash J; Canadian Task Force on Preventive Health Care.

CMAJ. 2001 Feb 20;164(4):469-76. Review. Erratum in: CMAJ 2001 Mar 20;164(6):753.

6.

A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.

Holland PA, Walls J, Boggis CR, Knox F, Baildam AD, Bundred NJ.

Br J Cancer. 1996 Nov;74(10):1643-6.

7.

Women doctors' use of hormone replacement therapy. High prevalence of use is not confined to doctors.

Banks E, Crossley B, English R, Richardson A.

BMJ. 1996 Mar 9;312(7031):638. No abstract available.

9.

Screening for breast cancer. Maximise compliance as well as radiological sensitivity.

Anderson TJ, Alexander FE, Kirkpatrick AE.

BMJ. 1995 Apr 15;310(6985):1002-3. No abstract available.

Supplemental Content

Support Center